Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Ellis JA, Gill BJ, Pisapia D, Winfree CJ. Superficial temporal artery pseudoaneurysm following trigeminal nerve stimulator placement. Neuromodulation. 2014;17(8):788-90.

Taplin M-, Montgomery B, Logothetis CJ, Bubley GJ, Richie JP, Dalkin BL, et al. Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study. J Clin Oncol. 2014;32(33):3705-15.

Hu Z, Chen K, Li W, Tyler JK. Transcriptional and genomic mayhem due to aging-induced nucleosome loss in budding yeast. Microb Cell. 2014;1(4):133-136.

Jawed SI, Busam K, Wang X, Horwitz S, Querfeld C. Cutaneous hemophagocytosis after alemtuzumab injection in a patient with Sézary syndrome. JAMA Dermatol. 2014;150(9):1021-3.

Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176-187.

Xylinas E, Cha EK, Khani F, Kluth LA, Rieken M, Volkmer BG, et al. Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. J Urol. 2014;191(3):830-41.

Kim SY, Baik K-, Baek K-, Chah K-, Kim KA, Moon G, et al. S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway. Mol Cell Biol. 2014;34(3):510-21.

Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, et al. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle. 2014;13(23):3670-84.

Otto B, Barbieri C, Lee R, Te AE, Kaplan SA, Robinson B, et al. Incidental prostate cancer in transurethral resection of the prostate specimens in the modern era. Adv Urol. 2014;2014:627290.

Valencia T, Kim JY, Abu-Baker S, Moscat-Pardos J, Ahn CS, Reina-Campos M, et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell. 2014;26(1):121-135.